(Q28249293)

1

0 references

Helen G Ding

2

0 references

Paolo Gattuso

3

0 references

Richard A Prinz

4

0 references

Xiulong Xu

Management of a solitary thyroid nodule

5

0 references

language of work or name

English

0 references

publication date

1 June 2005

0 references

published in

Cancer

0 references

volume

103

0 references

issue

11

0 references

page(s)

2261-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Anaplastic spindle-cell and giant-cell tumors of the thyroid gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Genetic alterations in human epithelial thyroid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

BRAF T1796A transversion mutation in various thyroid neoplasms.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

BRAF mutations are associated with some histological types of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

BRAF mutations in papillary carcinomas of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Molecular pathogenesis of thyroid nodules and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021

p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21073

7 January 2021